Scientists develop scans that light up aggressive cancer tumors for better treatment

byKing's College London[18F]FSPG PET can differentiate NRF2-high from NRF2-low tumors when grown orthotopically in the lungs of mice. Credit:Nature Communications(2024) DOI: 10.1

Updated on: January 22,2025 0

Scientists develop scans that light up aggressive cancer tumors for better treatment

byKing's College London[18F]FSPG PET can differentiate NRF2-high from NRF2-low tumors when grown orthotopically in the lungs of mice. Credit:Nature Communications(2024) DOI: 10.1

Updated on:January 22,2025 0

Immunosuppression study helps understand why some prostate cancer treatments do not work as expected

byTampere UniversityOn the left is a tissue sample from the prostate stained with hematoxylin and eosin. Hematoxylin stains the nuclei blue or purple because it binds to DNA, and eosin stains th

Updated on: December 21,2024 0

Immunosuppression study helps understand why some prostate cancer treatments do not work as expected

byTampere UniversityOn the left is a tissue sample from the prostate stained with hematoxylin and eosin. Hematoxylin stains the nuclei blue or purple because it binds to DNA, and eosin stains th

Updated on:December 21,2024 0

Digital twin research finds colon cancer cells can be reverted to normal cells

byThe Korea Advanced Institute of Science and Technology (KAIST)igure 6. Schematic diagram of the research results. Professor Kwang-Hyun Cho's research team developed a source technology to

Updated on: January 21,2025 0

Digital twin research finds colon cancer cells can be reverted to normal cells

byThe Korea Advanced Institute of Science and Technology (KAIST)igure 6. Schematic diagram of the research results. Professor Kwang-Hyun Cho's research team developed a source technology to

Updated on:January 21,2025 0

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3

Updated on: January 22,2025 0

Engineered CAR-NK cells offer an alternative approach to fighting leukemia

Engineered CAR-NK cells offer an alternative approach to fighting leukemiaby Markus Bernards,Goethe University Frankfurt am MainGeneration process and evaluation of CRISPR/Cas9 knockout for CAR3

Updated on:January 22,2025 0

Computational model for drug resistance assessment can improve treatment for leukemia and lung cancer

byLinnaeus UniversityCredit: Unsplash/CC0 Public DomainA new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most effective. The me

Updated on: December 21,2024 0

Computational model for drug resistance assessment can improve treatment for leukemia and lung cancer

byLinnaeus UniversityCredit: Unsplash/CC0 Public DomainA new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most effective. The me

Updated on:December 21,2024 0

Changes in blood cell production over the lifetime could impact leukemia outcomes

by Susanne Clara Bard,University of California - San DiegoCredit: Unsplash/CC0 Public DomainResearchers at University of California San Diego School of Medicine and their colleagues have develop

Updated on: December 21,2024 0

Changes in blood cell production over the lifetime could impact leukemia outcomes

by Susanne Clara Bard,University of California - San DiegoCredit: Unsplash/CC0 Public DomainResearchers at University of California San Diego School of Medicine and their colleagues have develop

Updated on:December 21,2024 0

How breast cancer cells survive in bone marrow after remission

byUniversity of MichiganGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI170953A study from researchers at the University of Michigan and the Unive

Updated on: December 21,2024 0

How breast cancer cells survive in bone marrow after remission

byUniversity of MichiganGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI170953A study from researchers at the University of Michigan and the Unive

Updated on:December 21,2024 0

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Updated on: January 22,2025 0

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Updated on:January 22,2025 0

Auto hematopoietic cell transplant not beneficial for mantle cell lymphoma with undetectable residual disease

by Elana GotkineAutologous hematopoietic cell transplant (auto-HCT) is not beneficial for patients with mantle cell lymphoma (MCL) in first complete remission (CR) with undetectable minimal residual d

Updated on: December 21,2024 0

Auto hematopoietic cell transplant not beneficial for mantle cell lymphoma with undetectable residual disease

by Elana GotkineAutologous hematopoietic cell transplant (auto-HCT) is not beneficial for patients with mantle cell lymphoma (MCL) in first complete remission (CR) with undetectable minimal residual d

Updated on:December 21,2024 0

How individual mutations of the tumor suppressor p53 affect pancreatic carcinomas

byUniversity of KonstanzMetabolic profile of p53 mutant variants in pancreatic cancer. Credit:Journal of Experimental & Clinical Cancer Research(2024). DOI: 10.1186/s13046-024-03

Updated on: December 21,2024 0

How individual mutations of the tumor suppressor p53 affect pancreatic carcinomas

byUniversity of KonstanzMetabolic profile of p53 mutant variants in pancreatic cancer. Credit:Journal of Experimental & Clinical Cancer Research(2024). DOI: 10.1186/s13046-024-03

Updated on:December 21,2024 0

Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri

Updated on: January 22,2025 0

Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri

Updated on:January 22,2025 0

Survival rates for incurable larynx cancer investigated for first time

byNewcastle UniversityKaplan Meier Survival Curves with associated estimated survival rates for entire cohort. Credit:Clinical Otolaryngology(2024). DOI: 10.1111/coa.14260First-of-it

Updated on: January 21,2025 0

Survival rates for incurable larynx cancer investigated for first time

byNewcastle UniversityKaplan Meier Survival Curves with associated estimated survival rates for entire cohort. Credit:Clinical Otolaryngology(2024). DOI: 10.1111/coa.14260First-of-it

Updated on:January 21,2025 0